How do you pay?

How to pay the least

Ask for the cash price

Conexxence

Conexxence is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Conexxence’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameConexxence
Authorized genericdenosumab
Regular genericdenosumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Conexxence?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Conexxence’s maker. Ask the pharmacy for Conexxence’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Conexxence itself, from the same company, sold without the brand name, and usually for less. For now Conexxence is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

Conexxence is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Conexxence’s cash price, or your plan what it charges.

What it’s used for

What the FDA label says

Conexxence is a RANK ligand (RANKL) inhibitor indicated for treatment:

  • of postmenopausal women with osteoporosis at high risk for fracture
  • to increase bone mass in men with osteoporosis at high risk for fracture
  • of glucocorticoid-induced osteoporosis in men and women at high risk for fracture
  • to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer
  • to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer

Source: the FDA label for Conexxence (Fresenius Kabi USA, LLC), December 15, 2025. Full label on DailyMed 

Good to know